Healthcare
Tuesday, November 8, 2016
BRIEF-Asterias Biotherapeutics reports treatment of first spinal cord injury patient with maximum dose of ast-opc1 in scistar clinical trial
* Asterias Biotherapeutics announces treatment of first
spinal cord injury patient with maximum dose of ast-opc1 in
scistar clinical trial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment